Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

923.51 -18.09 (-1.92%)
Streaming Delayed Price Updated: 9:56 AM EDT, Jul 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
98 99 Next >
If You Invested $100 In This Stock 20 Years Ago, You Would Have $900 Today
Via Benzinga
These 5 Wildly Popular High-Flying Stocks of 2023 Could Be Duds in the Rest of 2024, According to Wall Street
Analysts have not-so-great expectations going forward for these huge winners. 
Via The Motley Fool
Prediction: This Will Be the First Trillion-Dollar Healthcare Stock
This company is currently firing on all cylinders. 
Via The Motley Fool
Is It Too Late to Buy Eli Lilly Stock?
Eli Lilly is now the most valuable healthcare stock in the world. 
Via The Motley Fool
24 Dividend Growth Stocks to Buy and Hold in 2024
Dividends are good. Growing dividends are even better. 
Via The Motley Fool
Here's What Investors Should Expect From Eli Lilly Stock in 2024
More headlines on the horizon. 
Via The Motley Fool
Why Eli Lilly Stock Tumbled on Thursday
Investors were a bit concerned about an industrywide move. 
Via The Motley Fool
Is Lilly Getting Silly?
An old-school drug company, Eli Lilly (LLY), has worked its way into the 
Via Talk Markets
Unpacking the Latest Options Trading Trends in Eli Lilly
Via Benzinga
Will Eli Lilly Be Worth More Than Meta Platforms by 2030?
It would be quite the accomplishment for the drugmaker. 
Via The Motley Fool
3 High-Flying Stocks That Could Soar Even More in 2024
These big winners could keep the momentum going. 
Via The Motley Fool
S&P 500 Shatters Records: The Top-Performing Stocks In January 2024
2023 was a historical milestone for S&P 500 as it once again surpassed record highs, largely due to tech giants and artificial intelligence. Top gainers were NVIDIA, Meta Platforms, and AMD. 
Via Benzinga
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
Healthcare Giant Eli Lilly Under FDA Lens Again For Manufacturing Lapses
Eli Lilly faces FDA scrutiny with eight deficiencies at its Branchburg plant, raising concerns on Emgality's manufacturing. 
Via Benzinga
Exposures Product Safety
Eli Lilly and Company (NYSE: LLY) Records 52-Week High Tuesday Morning
Via Investor Brand Network
Inflation-Busting Price Hikes For Ozempic, Mounjaro And Others: Are Drugmakers Profiteering?
Pharmaceuticals prices are already up in 2024: Can inflation-beating hikes be justified? 
Via Benzinga
Balancing Act: The Ultimate Guide To Large-Cap Growth Stocks With Low Risk
Via Benzinga
Eli Lilly's Blockbuster Diabetes Drug Mounjaro Set To Enter New Markets Amid Manufacturing Boost
Discover Eli Lilly's global expansion plans for weight-loss drug Mounjaro in new countries. CEO David Ricks hints at potential U.K. launch. Explore our strategic manufacturing capacity expansion. 
Via Benzinga
2 biotechs with promising weight-loss drugs coming
Clinical weight-loss medications have been making headlines as GLP-1 drugs like Novo Nordisk A/S (NYSE: NVO) owned Ozempic and Wegovy and Eli Lilly and Co. 
Via MarketBeat
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
These 2 Top Healthcare Stocks Declared Dividend Raises in 2023
For different reasons, both Eli Lilly and UnitedHealth are doing well enough to enact substantial dividend raises. 
Via The Motley Fool
3 Pricey Stocks I'll Be Watching Like a Hawk in 2024
Good things come to those who wait. 
Via The Motley Fool
These 9 Stocks Are Running To Start 2024
The S&P 500 is up just 0.2% in 2024. These stocks are off to a strong start. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Move Over, Novo Nordisk -- This Is the Pharmaceutical Company I am Most Bullish On in 2024
Novo Nordisk may dominate the weight management space, but pharma giant Eli Lilly is quickly gaining steam. 
Via The Motley Fool
After Surging 53% in 2023, This Pharmaceutical Stock Might Be About to Crash. Here's Why I'm Probably Wrong
The rise of Ozempic and Wegovy helped Novo Nordisk stock surge over 50% last year. 
Via The Motley Fool
3 Unstoppable Stocks to Buy in 2024
These stocks appear to be on a clear path to continued growth. 
Via The Motley Fool
Portfolio Protection: 7 Risky Stocks to Drop Right Now
Ahead of further or unforeseen challenges, if you own any of these seven risky stocks, now's the time to bail. 
Via InvestorPlace
Evolving Landscape For Alzheimer's Blood Tests Gains Momentum Amid Inaccuracy Concerns
A less invasive alternative to PET scans, these tests offer quick identification for emerging treatments. Learn more about the latest advancements in Alzheimer's detection. 
Via Benzinga
FDA Finds No Evidence Weight-Loss Drugs Cause Suicidal Thoughts
The FDA released an update on Thursday stating that its preliminary review did not find definitive evidence that the drugs cause suicidal thoughts or actions. However, the FDA investigation will... 
Via Benzinga
Exposures Product Safety
3 Stocks to Buy in the Booming Field of Gene Editing
As the promise of gene editing moves closer to being a reality, these gene editing stocks have the opportunity for long-term gains. 
Via InvestorPlace
Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance
Pharmaceutical companies, including Amgen Inc (NASDAQ: AMGN) and Pfizer Inc (NYSE: PFE), are strategically positioning themselves to tap into the  
Via Benzinga
< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
98 99 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.